Keros Therapeutics News

Truist Securities Maintains Buy on Keros Therapeutics, Maintains $100 Price Target

BenzingaJun 19 01:48

HC Wainwright & Co. Reiterates Buy on Keros Therapeutics, Maintains $100 Price Target

BenzingaJun 18 18:25

Keros Therapeutics Analyst Ratings

BenzingaJun 18 18:24

Analysts' Top Healthcare Picks: Revolution Medicines (RVMD), Keros Therapeutics (KROS)

TipRanksMay 10 13:20

Keros Therapeutics Analyst Ratings

BenzingaMay 9 19:55

HC Wainwright & Co. Reiterates Buy on Keros Therapeutics, Maintains $100 Price Target

BenzingaMay 9 19:56

Buy Rating Reaffirmed for Keros Therapeutics as KER-050 Advances Towards Phase 3 for MDS Treatment

TipRanksMay 9 18:36

Analysts' Top Healthcare Picks: Ascendis Pharma (ASND), Keros Therapeutics (KROS)

TipRanksMay 9 18:20

Buy Rating Affirmed for Keros Therapeutics: Promising Pipeline and Strong Financial Health

TipRanksMay 9 17:19

Buy Rating Affirmed for Keros Therapeutics Amid FDA Approval Landscape and Market Opportunity for KER-012

TipRanksMar 29 15:05

Keros Therapeutics Analyst Ratings

BenzingaMar 28 00:47

Piper Sandler Maintains Overweight on Keros Therapeutics, Maintains $105 Price Target

BenzingaMar 28 00:48

Analysts Have Conflicting Sentiments on These Healthcare Companies: Argenx Se (ARGX), Iridex (IRIX) and Keros Therapeutics (KROS)

TipRanksMar 27 20:40

Piper Sandler Sticks to Its Buy Rating for Keros Therapeutics (KROS)

TipRanksMar 27 19:05

Strong Buy Rating for Keros Therapeutics Amid Favorable LR-MDS Treatment Landscape and Regulatory Environment

TipRanksMar 19 13:37

Keros Therapeutics Analyst Ratings

BenzingaMar 14 01:22

Truist Financial Sticks to Their Buy Rating for Keros Therapeutics (KROS)

TipRanksMar 13 19:35

Keros Therapeutics (KROS) Gets a Buy From Truist Financial

TipRanksMar 6 21:06

Keros Therapeutics Analyst Ratings

BenzingaMar 1 19:37

Analysts' Opinions Are Mixed on These Healthcare Stocks: Keros Therapeutics (KROS), Veeva Systems (VEEV) and Capricor Therapeutics (CAPR)

TipRanksMar 1 19:20